Concepedia

Morgan Eikanger

ME

4

Publications

85

Citations

4

H-Index

2021

Active since

Affiliations

University of South Dakota(Current)

South Dakota State University

Morgan Eikanger is an author at University of South Dakota specializing in biomolecular engineering, medicine, and nanoparticles.

ORCID

Top concepts

Publications per year

2021–2023

4

Publications

4

UBXN2A suppresses the Rictor-mTORC2 signaling pathway, an established tumorigenic pathway in human colorectal cancer

Sanam Sane, Rekha Srinivasan, Rashaun Potts et al. · Oncogene · 2023 · 32 citations · Full text

Enhancing Anti-Tumorigenic Efficacy of Eugenol in Human Colon Cancer Cells Using Enzyme-Responsive Nanoparticles

Nisitha Wijewantha, Sanam Sane, Morgan Eikanger et al. · Cancers · 2023 · 23 citations · Full text

Targeting Colon Cancer Cells with Enzyme-Triggered Casein-Gated Release of Cargo from Mesoporous Silica-Based Nanoparticles

Nisitha Wijewantha, Morgan Eikanger, Ryan Antony et al. · Bioconjugate Chemistry · 2021 · 20 citations · Full text

, , +17

Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model

Jessica Freeling, Jamie L. Scholl, Morgan Eikanger et al. · Cell Death Discovery · 2022 · 10 citations · Full text

Rows per page

1–4 of 4